Home ›
Trademark Categories ›
Pharmaceuticals ›
2016 ›
RH ›
RHINOSUL
Trademark search for:
RHINOSUL
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2016-04-14 — Application filed
2016-06-30 — Sn assigned for sect 66a appl from ib
2016-07-01 — Application filed
2016-07-05 — Application filed
2016-07-29 — Assigned to examiner
2016-08-08 — Final disposition recorded
2016-08-09 — Office action issued
2016-08-12 — Office action issued
2016-08-12 — Office action issued
2016-09-02 — Office action issued
2016-09-22 — Attorney/dom.rep.revoked and/or appointed
2016-09-22 — Teas revoke/app/change addr of atty/dom rep received
2016-09-23 — Office action issued
2016-09-23 — Correspondence received in law office
2016-09-24 — Teas/email correspondence entered
2016-10-07 — Approved for pub - principal register
2016-11-02 — Notification of notice of publication e-mailed
2016-11-22 — Published for opposition
2016-11-22 — Official gazette publication confirmation e-mailed
2017-02-07 — Registered-principal register
2017-05-07 — Final disposition recorded
2017-05-26 — Final disposition recorded
2017-05-26 — Final disposition recorded
2017-06-17 — Final disposition recorded
2022-02-07 — Courtesy reminder - sec. 71 (6-yr) e-mailed
2022-06-19 — New representative at ib received
2023-08-18 — Cancelled section 71
2023-08-18 — Final status recorded
2024-04-18 — Total invalidation of reg ext protection created
2024-04-30 — Total invalidation of reg ext protection sent to ib
2024-04-30 — Invalidation processed
2024-05-21 — Total invalidation processed by the ib
Owner Information
Paradigm Biopharmaceuticals Ltd.
AU
Paradigm Biopharmaceuticals Ltd.
AU
Paradigm Biopharmaceuticals Ltd.
AU
Correspondent
Kathryn Starshak K&L Gates LLP P.O. Box 1135 Chicago, IL 60690-1135 UNITED STATES
Filing Details
Filing Date:
2016-04-14
Status Date:
2023-08-18
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.